抗氧化能力檢測市場規模、佔有率和成長分析:按檢測類型、產品組合、最終用途領域和地區分類-2026-2033年產業預測
市場調查報告書
商品編碼
2102222

抗氧化能力檢測市場規模、佔有率和成長分析:按檢測類型、產品組合、最終用途領域和地區分類-2026-2033年產業預測

Antioxidant Capacity Assays Market Size, Share, and Growth Analysis, By Assay Type (ORAC Assays, FRAP Assays), By Product Component (Reagent Kits, Instruments), By End Use Sector, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024 年全球抗氧化能力測定市值為 58.4 億美元,預計到 2025 年將成長至 63.3 億美元,到 2033 年將成長至 120.7 億美元,在預測期(2026-2033 年)內複合年成長率為 8.4%。

全球抗氧化能力檢測試劑盒市場以分析試劑盒和儀器為特徵,這些試劑盒和儀器能夠測量化合物中和活性氧的能力,而活性氧在食品、製藥和化妝品行業中至關重要。消費者對健康增強型產品的興趣日益濃厚,以及對檢驗的抗氧化功效的監管要求日益嚴格,正在推動市場成長。基於螢光的檢測方法和自動化平台的進步提高了試劑盒的普及率,領導企業正在擴展其產品線,以滿足營養保健品開發商的需求。日益嚴格的監管審查迫使製造商投資檢驗且符合GMP標準的試劑盒。此外,人工智慧技術正在透過自動化數據解讀和提升處理能力,革新該領域,使實驗室能夠更準確、更有效率地處理更多樣本,最終滿足日益成長的抗氧化能力檢測需求。

全球抗氧化能力檢測市場的成長要素

隨著消費者對氧化壓力的認知不斷提高,製藥和生技公司正將抗氧化能力檢測納入藥物研發的早期階段。隨著研究重點轉向驗證產品的功效和安全性,研究人員優先考慮這些檢測方法,以突顯藥物的保護作用。這導致對先進檢測平台和試劑的需求增加。透過積極採用這些檢測方法,企業能夠提升候選藥物的市場價值,並吸引更多投資用於檢測技術。這一趨勢正在推動全球抗氧化能力評估解決方案市場在各個治療領域的擴張。

全球抗氧化能力測定市場的限制因素

準確測量抗氧化能力所需的複雜化學反應通常依賴昂貴的專有試劑,這使得小規模實驗室和新興市場參與者難以負擔。購買這些試劑的高昂成本會阻礙檢測方法的廣泛應用,導致各機構轉而尋求更經濟實惠的替代檢測方法。因此,預算限制,尤其是在研究經費有限的地區,會阻礙市場成長,並最終減緩對高品質抗氧化能力檢測解決方案的需求。這些經濟挑戰也阻礙了能夠提高檢測靈敏度和效率的先進技術的應用。

全球抗氧化能力檢測市場趨勢

全球抗氧化能力檢測市場正經歷一場強勁的變革,而高精度檢測自動化程度的提升正是推動這項變革的主要動力。實驗室正日益採用先進的自動化平台,這些平台利用微流體技術、高通量光學技術和人工智慧數據分析,從而顯著減少人工操作時間和結果變異性。這種向封閉式系統儀器的轉變,使得同時處理大量樣本成為可能,並能確保嚴格的重複性,從而提高藥物研發和食品安全檢測的效率。因此,該市場正在滿足監管機構對一致性抗氧化能力檢測的要求,促進永續的研究實踐,並最終維護全球供應鏈的健康。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

關鍵市場分析

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場魅力指數
  • PESTLE分析
  • 監理情勢

全球抗氧化能力檢測市場規模:依檢測類型分類

  • ORAC 檢測
  • FRAP 檢測
  • DPPH 測定
  • ABTS 檢測
  • 其他

全球抗氧化能力檢測市場規模:依產品成分分類

  • 試劑組
  • 裝置
  • 分析軟體

全球抗氧化能力檢測市場規模:依最終用途產業分類

  • 食品工業
  • 化妝品研究所
  • 藥物研發
  • 學術研究

全球抗氧化能力檢測市場規模:按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

競爭資訊

  • 前五大公司對比
  • 主要公司2025年的市場定位
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市場占有率分析,2025 年
  • 主要公司的完整公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 銷售收入年比比較(2023-2025 年)

主要公司簡介

  • Thermo Fisher Scientific Inc
  • Sigma-Aldrich
  • Merck KGaA
  • Bio-Rad Laboratories Inc
  • Danaher Corporation
  • Abcam plc
  • Cayman Chemical Company
  • Cell Biolabs Inc
  • Bioquochem SL
  • Promega Corporation
  • Agilent Technologies Inc
  • PerkinElmer Inc
  • Revvity Inc
  • Lonza Group AG
  • Becton Dickinson and Company
  • Enzo Life Sciences Inc
  • Geno Technology Inc
  • Kamiya Biomedical Company
  • RayBiotech Life Inc
  • Arbor Assays Inc

結論與建議

簡介目錄
Product Code: SQMIG35J2617

Global Antioxidant Capacity Assays Market size was valued at USD 5.84 Billion in 2024 and is poised to grow from USD 6.33 Billion in 2025 to USD 12.07 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global antioxidant capacity assay market is characterized by analytical kits and instruments that measure the capability of compounds to neutralize reactive oxygen species, essential for the food, pharmaceutical, and cosmetic sectors. Increasing consumer interest in health-promoting products and mounting regulatory demands for validated antioxidant claims have driven market growth. Advancements in fluorescence-based assays and automated platforms have enhanced adoption rates, with leading companies expanding their product offerings to meet the needs of nutraceutical developers. Regulatory scrutiny has heightened, pushing manufacturers to invest in validated, GMP-compliant kits. Moreover, AI technology is revolutionizing this sector by automating data interpretation and enhancing throughput, enabling labs to process more samples accurately and efficiently, ultimately fulfilling the rising demand for antioxidant testing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antioxidant Capacity Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antioxidant Capacity Assays Market Segments Analysis

Global antioxidant capacity assays market is segmented by assay type, product component, end use sector and region. Based on assay type, the market is segmented into ORAC Assays, FRAP Assays, DPPH Assays, ABTS Assays and Others. Based on product component, the market is segmented into Reagent Kits, Instruments and Analysis Software. Based on end use sector, the market is segmented into Food Industry, Cosmetic Labs, Pharmaceutical R&D and Academic Research. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Antioxidant Capacity Assays Market

Increasing awareness among consumers regarding oxidative stress is motivating pharmaceutical and biotechnology companies to integrate antioxidant capacity assays into the early stages of drug development. This focus on demonstrating product efficacy and safety has led researchers to emphasize these assays to highlight protective effects. Consequently, there is a rising demand for sophisticated testing platforms and reagents. By proactively incorporating these measurements, companies enhance the perceived value of their therapeutic candidates, inviting further investment in assay technologies. This trend is contributing to the expansion of the global market for solutions aimed at evaluating antioxidant capacity across various therapeutic areas.

Restraints in the Global Antioxidant Capacity Assays Market

The intricate chemistry involved in accurately measuring antioxidant capacity frequently depends on proprietary reagents that are priced at a premium, which can restrict access for smaller laboratories and participants in emerging markets. The elevated costs associated with these acquisitions can deter widespread implementation of assays, leading organizations to focus on more affordable testing alternatives. As a result, budget limitations hinder market growth, especially in areas with limited research funding, ultimately dampening the demand for high-quality antioxidant assay solutions. These financial challenges also impede the integration of advanced technologies, which could improve the sensitivity and efficiency of assays.

Market Trends of the Global Antioxidant Capacity Assays Market

The Global Antioxidant Capacity Assays market is experiencing a robust transformation driven by a surge in precision assay automation. Laboratories are increasingly adopting advanced automated platforms that utilize microfluidic handling, high-throughput optics, and AI-driven data interpretation, resulting in significant reductions in hands-on time and variability in results. This shift towards closed-system instruments allows for concurrent processing of numerous samples while ensuring strict reproducibility, enhancing efficiency in pharmaceutical development and food safety testing. As a result, the market is aligning with regulatory expectations for consistent antioxidant measurements and fostering sustainable research practices, ultimately supporting the integrity of global supply chains.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Antioxidant Capacity Assays Market Size by Assay Type & CAGR (2026-2033)

  • Market Overview
  • ORAC Assays
  • FRAP Assays
  • DPPH Assays
  • ABTS Assays
  • Others

Global Antioxidant Capacity Assays Market Size by Product Component & CAGR (2026-2033)

  • Market Overview
  • Reagent Kits
  • Instruments
  • Analysis Software

Global Antioxidant Capacity Assays Market Size by End Use Sector & CAGR (2026-2033)

  • Market Overview
  • Food Industry
  • Cosmetic Labs
  • Pharmaceutical R&D
  • Academic Research

Global Antioxidant Capacity Assays Market Size & CAGR (2026-2033)

  • North America (Assay Type, Product Component, End Use Sector)
    • US
    • Canada
  • Europe (Assay Type, Product Component, End Use Sector)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Assay Type, Product Component, End Use Sector)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Assay Type, Product Component, End Use Sector)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Assay Type, Product Component, End Use Sector)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Thermo Fisher Scientific Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sigma-Aldrich
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abcam plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cayman Chemical Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cell Biolabs Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioquochem S L
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revvity Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton Dickinson and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Enzo Life Sciences Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Geno Technology Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kamiya Biomedical Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RayBiotech Life Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arbor Assays Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations